The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
The closing price of Apellis Pharmaceuticals Inc (NASDAQ: APLS) was $24.37 for the day, down -3.22% from the previous closing price of $25.18. In other words, the price has decreased by -$3.22 from its previous closing price. On the day, 1.5 million shares were traded. APLS stock price reached its highest trading level at $25.275 during the session, while it also had its lowest trading level at $24.27.
Ratios:
Our analysis of APLS’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 3.81 and its Current Ratio is at 4.25. In the meantime, Its Debt-to-Equity ratio is 2.06 whereas as Long-Term Debt/Eq ratio is at 2.03.
On November 21, 2024, Morgan Stanley started tracking the stock assigning a Equal-Weight rating and target price of $31.
On October 25, 2024, RBC Capital Mkts started tracking the stock assigning a Sector Perform rating and target price of $25.RBC Capital Mkts initiated its Sector Perform rating on October 25, 2024, with a $25 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 05 ’25 when Watson David O. sold 5,569 shares for $25.10 per share. The transaction valued at 139,789 led to the insider holds 138,730 shares of the business.
DAVID OSBORNE WATSON bought 5,569 shares of APLS for $139,789 on Mar 05 ’25. On Feb 11 ’25, another insider, DeLong Mark Jeffrey, who serves as the Chief Business & Strat Officer of the company, sold 363 shares for $28.54 each. As a result, the insider received 10,360 and left with 83,945 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, APLS now has a Market Capitalization of 3058824960 and an Enterprise Value of 3112467456. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.91 while its Price-to-Book (P/B) ratio in mrq is 13.28. Its current Enterprise Value per Revenue stands at 3.983 whereas that against EBITDA is -19.074.
Stock Price History:
The Beta on a monthly basis for APLS is 0.78, which has changed by -0.57049704 over the last 52 weeks, in comparison to a change of 0.07903516 over the same period for the S&P500. Over the past 52 weeks, APLS has reached a high of $59.91, while it has fallen to a 52-week low of $23.77. The 50-Day Moving Average of the stock is -14.90%, while the 200-Day Moving Average is calculated to be -26.56%.
Shares Statistics:
APLS traded an average of 1.88M shares per day over the past three months and 1635680 shares per day over the past ten days. A total of 124.50M shares are outstanding, with a floating share count of 104.48M. Insiders hold about 16.76% of the company’s shares, while institutions hold 99.44% stake in the company. Shares short for APLS as of 1740700800 were 20815049 with a Short Ratio of 11.04, compared to 1738281600 on 17055810. Therefore, it implies a Short% of Shares Outstanding of 20815049 and a Short% of Float of 22.639999.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
